Objectives. To determine whether type IX collagen-related peptides can be detected in the synovial fluids of arthritis patients and to assess their potential as molecular markers of arthritis.
Type IX belongs to the FACIT (Fibril Associated type IX is covalently linked to type II collagen via Collagen with Interrupted Triple-helix) group of collapyridinoline cross-links [9] and is located on the surface gens [1]. It is described as a 'minor' collagen of articular of the type II fibrils where it may function to regulate cartilage since it is present in relatively small amounts the type II fibril diameters [10] and/or matrix (~1-2% of the total collagen in adult cartilage) cominteractions. pared to the 'major' type II collagen (~90%). The type Both rheumatoid arthritis (RA) and osteoarthritis IX collagen molecule is composed of three collagenous (OA) are characterized by the degradation of the articdomains separated by short non-triple helical regions ular cartilage. The first irreversible step in the disease which are particularly sensitive to enzymic attack [2] [3] [4] [5] [6] .
process is the breakdown of the collagen network which The presence of a chondroitin sulphate side chain is essential for maintaining the integrity of the tissue. attached to the a2 chain [7] and the large globular
The accessibility of type IX collagen on the surface of N-terminal domain of the a1 chain [8] are thought to the type II fibrils and its susceptibility to enzyme digesfacilitate interactions of type IX collagen with other tion led us to hypothesize that fragments of type IX matrix components. Furthermore, it is now known that collagen may be among the first to be released into the synovial fluid when the collagen network of the articular cartilage is degraded. Such fragments, if they can be evidence that breakdown of the cartilage matrix is patients with OA of the knee (defined as use-related pain with radiographic evidence of both joint space occurring, rather than the fragments arising simply from renewed synthesis of the collagenous components. This narrowing and osteophytes), comprising five females, two of whom had synovial fluid aspirated from both is particularly relevant to type IX collagen fragments since they are covalently bound to type II fibrils in the knees, with a mean age of 75.2 yr; four samples from healthy volunteers comprising three males and one cartilage matrix via pyridinoline cross-links.
The usefulness of body fluid chemical markers in the female with a mean age of 42.8 yr with no history of knee pain or joint disease who consented to arthrocentdiagnosis and monitoring of certain diseases is undisputed. Ideally, such markers should be specific and easy esis for the collection of normal synovial fluids. The pathological synovial fluids were coded and supplied to to assay. However, the search for suitable markers for arthritis, especially those which provide early indications the laboratory as a set of samples 'blind' with respect to their origin (RA or OA patients) or diagnostic of disease, has proved difficult. Pyridinoline cross-links in urine have been reported to be elevated in OA and history. These samples were not decoded until after all the analytical data had been collected. The normal RA [11] , but the tissue of origin cannot be identified. Synovial fluid markers are more likely to be specific for synovial fluids were collected subsequently. All synovial fluid samples were aspirated from the knee joint, using tissue damage within an affected joint and thus more relevant than serum markers, which are not necessarily the lateral approach and a 23 gauge needle. They were then centrifuged at 4000 r.p.m. to remove any cartilage specific, are removed quickly from the circulation and may be diluted by turnover products from unaffected chips and cells, and collected into Tris buffer containing protease inhibitors in the ratio of 1 volume of synovial joints or other tissue sources [12, 13] . Possible candidates for use as molecular markers include cytokines, profluid:2 volumes of buffer, such that the final buffer concentration was 0.05  Tris (pH 7.5), 10 m ethyleneteinases and their inhibitors, matrix components and their fragments, and antibodies to these or other possible diaminetetraacetic acid ( EDTA), 10 m n-ethylmaleimide, 1 m phenylmethylsulphonyl fluoride (PMSF ), antigens [12] [13] [14] [15] [16] . It can be argued that cartilage matrix components are the most promising candidates for 1 mg/l trypsin inhibitor. Limited analyses only were possible on the normal fluids due to the small volumes markers since they relate to changes in the cartilage specifically rather than those in other tissues of the joint which could be removed. The total amount of synovial fluid present in each healthy joint was assumed to such as the synovium. Proteoglycan fragments or epitopes have been extensively studied, although there are be ≤1 ml. Ethical committee approval was obtained for the some difficulties in interpretation since proteoglycan can be lost from the cartilage in situations not indicative of study. irreversible degradation, such as during exercise, and
Collagen content are also rapidly replaced. More recent work suggests that they can provide a useful measure of the balance Collagen contents were determined by hydroxyproline assays and calculated on the basis of a 14% hydroxyprobetween synthesis and degradative processes [17, 18] in both RA and OA. The normal rate of turnover of the line content, the value generally accepted as present in the fibrillar collagens. Synovial fluid samples were hydrocollagen in articular cartilage is slow, and although new synthesis may be stimulated in arthritis and cannot be lysed with 6  HCl and assayed in duplicate for hydroxyproline using an autoanalyser by oxidation with excluded as a source of collagen fragments in synovial fluids, these fragments are more likely to be derived Chloramine T and colour development with paradimethylaminobenzaldehyde [21] . from degradation of the mature matrix. We have previously published preliminary results indicating the presPyridinoline assays ence of type IX-related components in the synovial fluids of arthritis patients [19, 20] . Here, we describe Acid-hydrolysed synovial fluid samples were analysed for the cross-link pyridinoline by reversed-phase HPLC the detection of type IX immunoreactive peptides in a set of synovial fluids from a carefully diagnosed group using fluorescence detection [22] . Single analyses only were possible due to limited sample volumes. of arthritis patients and the comparison with synovial fluids from healthy volunteers to assess their potential Treatment of synovial fluids for peptide identification as early markers for arthritic diseases.
To overcome difficulties due to the viscosity and the high globular protein content of the synovial fluids, samples were fractionated by precipitation with 0.5  Materials and methods acetic acid, followed by centrifugation at 10 000 r.p.m.
Subjects and synovial fluid samples
The resultant pellets were freeze-dried while the supernatants were dialysed against 0.005  acetic acid prior Three groups of samples were studied: seven samples from six patients with classical RA (ACR criteria) and to freeze-drying. Precipitated and supernatant fractions were thereafter analysed separately. active synovitis of the knee joint requiring therapeutic aspiration, comprising one male and five females, one Some fractionated samples were also digested with either pepsin at a ratio of 1:10 dry weight of whom had synovial fluid aspirated from both knees, with a mean age of 56.8 yr; seven samples from five (pepsin:sample) in 0.5  acetic acid or with cyanogen Western blotting was carried out after SDS-PAGE [25], and peptides localized using a range of polyclonal and monoclonal antibodies raised against purified collagens, previously characterized and of known specificities [26 ] : to the relevant patient groups, no significant differences (P = 0.096, unpaired t-test) were found between the goat anti-human type I collagen; rabbit anti-bovine type II collagen; goat anti-human type II collagen (Southern collagen concentrations present in the synovial fluids from RA patients (30.4 ± 5.0 mg/ml ) and from OA Biotechnology Associates); mouse anti-bovine type VI collagen (monoclonal ); rabbit anti-porcine type IX colpatients (26.9 ± 4.7 mg/ml ). Later, the collagen concentrations present in synovial fluids from healthy volunlagen (recognizes predominantly the COL 2 region); rabbit anti-porcine type XI collagen. Labelled peptides teers (52.9 ± 40.1 mg/ml ) were also found not to differ significantly (P = 0.072, Kruskal-Wallis non-parametric were detected using an alkaline phosphatase-conjugated second antibody with a substrate consisting of a mixture ANOVA) from those of either patient group. However, the total amounts of collagen in the arthritic joint fluids of 5-bromo-4-chloro-3-indolyl phosphate and Nitro Blue Tetrazolium (Sigma).
were higher than those of normal fluids due to the increase in the volume (assuming that the total volume Sequencing of synovial fluid in a normal joint does not exceed 1 ml ). The collagen cross-link pyridinoline was detected N-terminal sequencing of peptide bands cut from Coomassie Blue-stained blots was conducted by the in both RA (66.0 ± 57.9 pmol/ml ) and OA (20.6 ± 7.1 pmol/ml ) synovial fluids. Although there is a large Molecular Recognition Centre, Bristol University, and matched to known sequences using computer analysis difference between the mean values and a trend to higher levels in RA and OA, there is no significant difference (Genetics Computer Group, Sequence Analysis Software Package, 1991).
(P = 0.26, Mann-Whitney test) in the amounts present between the two patient groups ( Table 2 ) due mainly to Statistical methods the large variability in the amounts present in the synovial fluids from the RA patients. Levels of pyridinoParametric statistical tests (unpaired t-test) were used where sample sizes allowed and .. values were suffiline calculated on the basis of moles/mole of collagen are within the expected range, but again revealed no ciently similar. Where these criteria could not be fulfilled, the appropriate non-parametric test was used ( Kruskalsignificant difference between the two patient groups. The small amounts of normal synovial fluids were Wallis non-parametric ANOVA test or Mann-Whitney test).
insufficient for us to conduct this assay on these samples. In order to identify the collagenous components present in the synovial fluids, they were fractionated by Results precipitation with acid, which reduced the viscosity of the fluids, enabling both the pellets and supernatants to Measurable amounts of collagen were detected in all the synovial fluids ( Table 1) , although the collagen content be subjected to SDS-PAGE (Fig. 1) . The predominant protein in both the precipitated and supernatant samples of the synovial fluids from arthritis patients represented only between 0.05 and 0.1% of the total dry weight of revealed by Coomassie Blue staining is human serum albumin. The precipitated samples contain a greater material. When the samples were decoded and assigned proportion of high-molecular-weight material, while both fractions contain many small-molecular-weight peptides. Hydroxyproline assays on the separate fractions indicated that 90-95% of the collagen is present in the acid precipitates of the synovial fluids. However, none of the peptide bands in any of the synovial fluid samples could be judged to correspond definitively to those from standard collagen preparations or their known enzyme-derived fragments.
Immunoblotting was carried out to further the identification of the peptides. the loading of each sample, as indicated by the degree of Coomassie Blue staining of the human serum albumin (hsa) ( Fig. 4) , is similar. Although the difference is also samples was undertaken since it gives rise to clearly defined peptide patterns for standard collagens while evident in the reduced samples, there is an apparent loss of loading equivalence (Fig. 5) relative to human serum digesting other proteins to rather smaller peptides. Thus, it was predicted that recognizable cyanogen bromide albumin. If these reduced samples are loaded to apparent equivalence with respect to the human serum albumin, peptides would be released. However, the type IX immunoreactive peptides of 27K and 12K molecular the type IX immunoreactive peptides can also be detected in the normal samples. None of the type IX weights obtained by cyanogen bromide digestion of whole or acid-fractionated arthritis synovial fluids (Fig. 6 ) do immunoreactive peptides correspond to known enzymederived fragments of type IX collagen.
not correspond to the pattern of peptides derived from cyanogen bromide digestion of the purified type IX Cyanogen bromide digestion of the synovial fluid F. 4. Immunoblots of acid supernatant samples from arth-F. 2. Immunoblots of acid-precipitated samples from arthritis and normal synovial fluids, unreduced, after SDS-PAGE ritis and normal synovial fluids, unreduced, after SDS-PAGE on 10% polyacrylamide gels in a tricine buffer system, transfer on 10% polyacrylamide gels in a tricine buffer system, transfer to PVDF membranes and staining with Coomassie Brilliant to PVDF membrane and staining with Coomassie Brilliant Blue (A) or localization with the polyclonal antibody to type Blue (A) or localized with antibody to type I collagen (B). OA and RA are osteo-and rheumatoid arthritis synovial fluid IX collagen (B). OA and RA are osteo-and rheumatoid arthritis synovial fluid samples, numbers correspond to those samples, numbers correspond to those in Fig. 1 and Tables 1  and 2 ; N, normal synovial fluid samples; st2, type II collagen in Fig. 1 and Tables 1 and 2 ; N, normal synovial fluid samples; hsa, human serum albumin. standard; m, molecular weight markers (Amersham); hmw, high-molecular-weight material; hsa, human serum albumin.
F. 5.
Immunoblots of acid supernatant samples from arthritis and normal synovial fluids, reduced with 2% mercaptoethanol, after SDS-PAGE on 10% polyacrylamide gels in a tricine buffer system, transfer to PVDF membrane and staining F. 3. Immunoblots of acid-precipitated samples from arthwith Coomassie Brilliant Blue (A) or localization with the ritis and normal synovial fluids, reduced with 2% mercaptopolyclonal antibody to type IX collagen (B). OA and RA are ethanol, after SDS-PAGE on 10% polyacrylamide gels in a osteo-and rheumatoid arthritis synovial fluid samples, numtricine buffer system, transfer to PVDF membranes and stainbers correspond to those in Fig. 1 and Tables 1 and 2 ; N, ing with Coomassie Brilliant Blue (A) or localized with normal synovial fluid samples; hsa, human serum albumin. antibody to type I collagen (B). OA and RA are osteo-and rheumatoid arthritis synovial fluid samples, numbers correscollagen. Furthermore, all the immunoreactive peptides pond to those in Fig. 1 and Tables 1 and 2 ; N, normal synovial appeared to be sensitive to prolonged pepsin digestion, fluid samples; st2, type II collagen standard; m, molecular but resistant to digestion by collagenase or hyaluronidweight markers (Amersham); hmw, high-molecular-weight material; hsa, human serum albumin.
ase (results not shown). This suggests that these peptides peptides generated by cyanogen bromide treatment there were also low-level secondary sequences detectable against a rising glycine background. These were found to be similar to some type IX collagen sequences and support the suggestion that the peptide bands contain small type IX immunoreactive fragments bound to the major non-collagenous peptide.
Discussion
The main purpose of this study was to determine whether type IX-related peptides can be detected in the synovial fluids of arthritis patients and to assess their potential as molecular markers of arthritis. The study is unique in the use of a carefully collected and documented set of samples, including synovial fluids from normal volunteers, which are very difficult to obtain. Thus, the numbers of subjects in each patient group were necessarily small, making it difficult to attempt any correlations of synovial fluid findings with measures of disease activity, duration or severity, and no attempt was made to match patient groups and normal subjects by age or sex. that the total amount of collagen was highly elevated in fluids from the arthritic joints ( Table 1) . Levick [27] has described the importance of taking volume into considare not predominantly collagenous, but may carry small epitope-bearing fragments of type IX collagen.
eration, since the clearance of macromolecules is dependent on the intra-articular volume. Although this is not To investigate this possibility, we carried out N-terminal sequencing of the relevant peptides. These synonymous with synovial fluid volume alone, since macromolecules are excluded from some of that volume were cut out from areas of a Coomassie Blue-stained blot which corresponded to labelled bands on immunoby the hyaluronan gel while also being distributed through other tissues of the joint, e.g. the synovium, the blots. A tricine gel system was used to minimize the difficulties of a high glycine background, which is a synovial fluid volume does take some account of the increased clearance in arthritis due to an increased rate particular problem if collagenous sequences, themselves high in glycine, are present. Only peptides from the gels of synovial capillary fluid filtration and increased lymph flow. In reality, the picture is further complicated by of reduced samples were used since the unreduced peptide band was too closely situated to or overlapping factors such as the marker size, fluid turnover rate and phagocytosis, and Levick [27] cautions against the use the heavily loaded human serum albumin band. The sequences found and their identifications are listed in of a simple marker concentration as a quantitative measure of disease severity. Our results confirm this, Table 3 . This confirmed that the peptides are indeed largely non-collagenous, but it was also clear that in the but while it is possible that total collagen content may be the more relevant measurement, it seems of little articular cartilage as part of the disease process. Since these peptides are resistant to collagenase digestion and value in terms of a molecular marker since it reflects primarily the more easily measured difference in synovial sensitive to prolonged pepsin digestion, they are clearly not predominantly collagenous, but the reactivities of fluid volume.
A difference was found in the concentration of the some of these with the antibodies to type IX collagen do appear to be specific. It is possible that the collagencollagen cross-link pyridinoline in the synovial fluids of RA and OA patients which suggested a trend towards specific antibodies could bind non-specifically to the bands (50K and 27K ) subsequently identified as higher mean values in RA than in OA. However, there was a high level of variability between the individual immunoglobulins by sequencing. However, none of the collagen-specific antibodies used in this study were found RA samples which negated the statistical significance. Nevertheless, this variability may be important and to cross-react with or bind non-specifically to human serum albumin, the major protein identified by sequenreflect the variable nature of the disease process itself in RA, where the levels of inflammation, pannus formation cing in the type IX immunoreactive bands generated by cyanogen bromide treatment. The secondary sequences and disease activity differ markedly between patients and vary with time in individual patients. The presence found in these peptides (27K.CB and 12K.CB), although at a low level, do suggest that type IX-related material of pyridinoline indicates the degradation of a mature matrix, although the tissue of origin cannot be identified.
is also present, most likely as a small fragment bound in some way to the predominant peptide. Since some of Possible sources are cartilage, synovium, meniscus or bone. Approximately 25% of the pyridinoline from bone these peptides (50K and 27K ) can be demonstrated in both normal and arthritis synovial fluids, they have is in the form of lysyl pyridinoline, whereas only the hydroxylysyl form is found in other tissues. Levels of limited potential for use as molecular markers. It is possible that the ratio of high-molecular-weight to lowlysyl pyridinoline in these samples were too low to be detected, indicating that bone is unlikely to be the major molecular-weight type IX reactive components may be a useful indicator of disease, but would require careful source. Unfortunately, due to limited sample volumes, values from normal synovial fluids could not be obtained calibration. Since the sequencing data suggest that the small type IX immunoreactive peptides generated by for comparison.
SDS-PAGE revealed some interesting qualitative cyanogen bromide digestion (27K.CB and 12K.CB) are not related to those detected by simple acid fractionation differences between normal synovial fluids and those from arthritis patients. Some non-collagenous peptides of the synovial fluids, it would be interesting to determine whether similar peptides can also be generated by were observed to change with disease [28] , but are unrelated to type IX collagen and therefore not relevant cyanogen bromide digestion of normal synovial fluids. This was not possible in this study due to the small to the subject of this paper. High-molecular-weight collagenous material, found predominantly in the acidvolumes of normal synovial fluids available. However, the usefulness of these particular peptides as molecular precipitated fractions and identified as type I-and type IX-related components, is present in higher amounts in markers is questionable since cyanogen bromide treatment may not be considered as a desirable technique to the normal than the pathological fluids and represents a high proportion of the total collagen. Smaller molecube part of any routine diagnostic assay. Nevertheless, despite the limited potential for their practical use as lar weight type IX immunoreactive peptides found in the acid supernatant fractions initially seemed to be markers of arthritic diseases, this is the first report of type IX collagen-related fragments in synovial fluids. present only in the RA and OA synovial fluids ( Figs 4 and 5). However, when equivalent sample loadings relative to human serum albumin were used, similar
